Biography

<<Back

Karen L. Shoos, J.D.

Consultant, AABB International Technical Assistance, Division of Global Services

Ms. Shoos has been a director of Celldex since the merger between Celldex and AVANT Immunotherapeutics in March 2008 and had been a director of AVANT since May 2001. From May 2013 to September 2016, Ms. Shoos was Principal Investigator, AABB International Technical Assistance, a professional standards setting and accrediting organization in the fields of blood and cellular therapies, and from 1994 to 2013, she was the Chief Executive Officer. From 1984 to 1994, she held senior positions at the American Red Cross, including Acting Senior Vice President, Biomedical Services, as well as General Counsel and Secretary. Prior to the American Red Cross, Ms. Shoos was a lawyer in private practice. She received her B.A. from Yale University and J.D. from Case Western Reserve University.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline